Credit Suisse Ag Avidity Biosciences, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 66,776 shares of RNA stock, worth $2.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

66,776

Previous 50,328 32.68%

Holding current value

$2.08 Million

Previous $455,000 274.51%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$9.16 - $25.52 $150,663 - $419,752	16,448 Added 32.68%	66,776 $1.7 Million
Q4 2023 Feb 08, 2024	SELL	$4.87 - $9.37 $28,221 - $54,299	-5,795 Reduced 10.33%	50,328 $455,000
Q3 2023 Nov 13, 2023	SELL	$6.3 - $11.35 $156,655 - $282,229	-24,866 Reduced 30.7%	56,123 $358,000
Q2 2023 Aug 11, 2023	BUY	$10.62 - $17.34 $348,410 - $568,873	32,807 Added 68.09%	80,989 $898,000
Q1 2023 May 10, 2023	BUY	$15.35 - $25.65 $79,712 - $133,200	5,193 Added 12.08%	48,182 $739,000
Q4 2022 Feb 13, 2023	BUY	$10.06 - $22.66 $126,303 - $284,496	12,555 Added 41.25%	42,989 $953,000
Q3 2022 Nov 10, 2022	BUY	$15.46 - $23.43 $87,302 - $132,309	5,647 Added 22.78%	30,434 $497,000
Q2 2022 Aug 12, 2022	SELL	$11.18 - $20.5 $20,884 - $38,294	-1,868 Reduced 7.01%	24,787 $360,000
Q1 2022 May 16, 2022	BUY	$14.2 - $23.78 $511 - $856	36 Added 0.14%	26,655 $492,000
Q4 2021 Feb 14, 2022	BUY	$20.4 - $28.66 $68,564 - $96,326	3,361 Added 14.45%	26,619 $633,000
Q3 2021 Nov 12, 2021	BUY	$18.16 - $25.21 $422,365 - $586,334	23,258 New	23,258 $572,000
Q2 2021 Aug 16, 2021	SELL	$19.62 - $29.26 $211,582 - $315,539	-10,784 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$20.28 - $28.15 $291,950 - $405,247	-14,396 Reduced 57.17%	10,784 $235,000
Q4 2020 Feb 12, 2021	BUY	$24.73 - $35.12 $622,701 - $884,321	25,180 New	25,180 $642,000

Others Institutions Holding RNA

# of Institutions

258

Shares Held

108M

Call Options Held

517K

Put Options Held

717K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.62B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account